Vaccines for Respiratory Viruses-COVID and Beyond

Area of Science:

• Virology
• Immunology
• Vaccinology

Background:

• The COVID-19 pandemic highlighted the global threat of respiratory viruses.
• Influenza virus and respiratory syncytial virus (RSV) are significant public health concerns due to efficient transmission.
• Antigenic variation in these viruses necessitates continuous vaccine development and monitoring.

Purpose of the Study:

• To review the molecular mechanisms of pathogenesis and virulence for common respiratory viruses.
• To discuss current and emerging vaccine approaches against RSV, influenza, and SARS-CoV-2.
• To identify challenges in developing durable and potent vaccines, especially for at-risk populations.

Main Methods:

• Comprehensive literature review of viral pathogenesis.
• Analysis of molecular mechanisms of viral virulence.
• Review of ongoing vaccine development strategies and technologies.

Main Results:

• Respiratory viruses like RSV, influenza, and SARS-CoV-2 exhibit complex pathogenesis and virulence factors.
• Existing vaccines face challenges due to viral evolution and limitations in inducing long-lasting immunity.
• Next-generation vaccines require strategies to overcome reduced immune responses in elderly and immunocompromised individuals.

Conclusions:

• Understanding viral mechanisms is key to designing effective vaccines.
• Novel vaccine platforms are under development to address viral diversity and immune evasion.
• Advancing vaccine strategies will improve protection against severe respiratory infections.